GlassScriptPhysician profile
Joe A Shaw
NPI 1134267008
$3,728.46
in general payments reported to CMS, 2019-2025
31 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.08 · 2021: $1,787 · 2022: $928 · 2023: $568 · 2024: $60.12 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $597.54 | 2021-2023 | Relistor |
| Abbvie INC. | $445.31 | 2021-2025 | |
| Nevro Corp. | $330.03 | 2021-2022 | |
| Convatec INC. | $189.00 | 2025 | |
| Medtronic, INC. | $188.52 | 2021-2022 | |
| Horizon Therapeutics Plc | $185.73 | 2021-2023 | Uplizna, Krystexxa |
| Bioventus LLC | $169.36 | 2021 | |
| Scilex Pharmaceuticals INC. | $160.93 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $143.74 | 2021-2023 | Belbuca, Xtampza |
| Boston Scientific Corporation | $140.10 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $127.06 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $116.63 | 2025 | |
| Lundbeck LLC | $108.39 | 2021-2022 | |
| Protega Pharmaceutials INC | $92.13 | 2022-2023 | Roxybond |
| Spr Therapeutics, INC | $82.96 | 2019-2023 | Sprint Pns System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $77.62 | 2021 | |
| Allergan, INC. | $71.86 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $71.61 | 2021 | |
| Abbott Laboratories | $61.82 | 2022-2024 | Eterna, Proclaim |
| Grt US Holding, INC. | $61.26 | 2021-2022 | |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Alfasigma USA, INC. | $42.64 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $35.40 | 2021 | |
| Novo Nordisk INC | $32.23 | 2023 | Rybelsus |
| Pfizer INC. | $31.42 | 2021 | |
| Ibsa Pharma INC. | $24.31 | 2021 | |
| Radius Health, INC. | $23.65 | 2023 | Tymlos |
| Stimwave Technologies Incorporated | $19.71 | 2021 | |
| Baudax Bio INC. | $18.69 | 2021 | |
| Azurity Pharmaceuticals, INC. | $18.16 | 2023 | Horizant |
| Uswm, LLC | $15.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.